You are here

  • Home
  • Online First
  • CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)

Article info

Article menu

other Versions

Download PDFPDF
Clinical trial
CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)

Authors

  • David Cibula Gynaecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech RepublicCentral and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Martina Borčinová Gynaecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech RepublicCentral and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Roman Kocian Gynaecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech RepublicCentral and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic PubMed articlesGoogle scholar articles
  • David Feltl Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Sona Argalacsova Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Pavel Dvorak Department of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Daniela Fischerová Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech RepublicDepartment of Oncology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Pavel Dundr Central and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech RepublicDepartment of Pathology, Charles University and General University Hospital in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Jiri Jarkovsky Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic PubMed articlesGoogle scholar articles
  • Eva Höschlová Department of Psychology, Faculty of Arts, Charles University in Prague, Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Jiri Slama Gynaecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech RepublicCentral and Eastern European Gynecologic Oncology Group (CEEGOG), Prague, Czech Republic PubMed articlesGoogle scholar articles
  • Giovanni Scambia Dipartimento Scienze della Salute della Donna e del Bambino, Fondazione Policlinico Universitario A Gemelli IRCCS, Rome, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr David Cibula, Gynaecologic Oncology Centre, First Faculty of Medicine, Charles University and General University Hospital in Prague, 12000 Prague, Czech Republic; dc{at}davidcibula.cz
View Full Text

Citation

Cibula D, Borčinová M, Kocian R, et al
CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)
International Journal of Gynecologic Cancer Published Online First: 13 September 2022. doi: 10.1136/ijgc-2022-003918

Publication history

  • Accepted August 23, 2022
  • First published September 13, 2022.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.